Seroguard

DRUG2 trials

Sponsors

Pharmasyntez

Conditions

Adhesion

Phase 1

Safety and Tolerability of Seroguard Use

CompletedNCT03640559

PharmasyntezAdhesion

Start: 2015-05-19End: 2015-10-04Updated: 2019-05-03

Phase 2

Efficacy and Dose Ranging Study of Seroguard

CompletedNCT03660787

PharmasyntezAdhesion

Start: 2017-05-04End: 2018-01-23Updated: 2019-06-19